newsfilter
← Latest News
ClinicalTrials.gov·

Potential Drug Interaction Between ALXN2040 and Rosuvastatin - NCT05708573

Maximum observed plasma drug concentration during a dosing interval (Cmax) of rosuvastatin, Area under the concentration-time curve from time zero to the time of the last observed/measured nonzero concentration (AUC0-last) of rosuvastatin, Area under the concentration-time curve from time zero extrapolated to infinity (AUCinf) of rosuvastatin, (and 9 more...)